Ghent University Academic Bibliography

Advanced

Upregulation of MAPK negative feedback regulators and RET in mutant ALK neuroblastoma : implications for targeted treatment

Irina Lambertz, Candy Kumps, Shana Claeys UGent, Sven Lindner, Anneleen Beckers, Els Janssens, Daniel R Carter, Alex Cazes, Belamy B Cheung, Marilena De Mariano, et al. (2015) CLINICAL CANCER RESEARCH. 21(14). p.3327-3339
Please use this url to cite or link to this publication:
author
organization
year
type
journalArticle (original)
publication status
published
subject
keyword
MUTATED NEUROBLASTOMA, RECEPTOR TYROSINE KINASE, ACTIVATING MUTATIONS, SYMPATHETIC NEURONS, EXPRESSION PROFILES, THERAPEUTIC TARGET, MEK INHIBITION, GENE, MYCN, CANCER
journal title
CLINICAL CANCER RESEARCH
Clin. Cancer Res.
volume
21
issue
14
pages
3327 - 3339
Web of Science type
Article
Web of Science id
000359324000026
JCR category
ONCOLOGY
JCR impact factor
8.738 (2015)
JCR rank
12/213 (2015)
JCR quartile
1 (2015)
ISSN
1078-0432
DOI
10.1158/1078-0432.CCR-14-2024
language
English
UGent publication?
yes
classification
A1
additional info
the first two authors are share first authors; the last two authors are shared last authors
copyright statement
I have transferred the copyright for this publication to the publisher
id
5972343
handle
http://hdl.handle.net/1854/LU-5972343
date created
2015-06-01 15:53:04
date last changed
2017-04-07 14:38:51
@article{5972343,
  author       = {Lambertz, Irina and Kumps, Candy and Claeys, Shana and Lindner, Sven and Beckers, Anneleen and Janssens, Els and Carter, Daniel R and Cazes, Alex and Cheung, Belamy B and De Mariano, Marilena and De Bondt, An and De Brouwer, Sara and Delattre, Olivier and Gibbons, Jay and Janoueix-Lerosey, Isabelle and Laureys, Genevieve and Liang, Chris and Marshall, Glenn M and Porcu, Michael and Takita, Junko and Camacho-Trujillo, David and Van Den Wyngaert, Ilse and Van Roy, Nadine and Van Goethem, Alan and Van Maerken, Tom and Zabrocki, Piotr and Cools, Jan and Schulte, Johannes H and Vialard, Jorge and Speleman, Franki and De Preter, Katleen},
  issn         = {1078-0432},
  journal      = {CLINICAL CANCER RESEARCH},
  keyword      = {MUTATED NEUROBLASTOMA,RECEPTOR TYROSINE KINASE,ACTIVATING MUTATIONS,SYMPATHETIC NEURONS,EXPRESSION PROFILES,THERAPEUTIC TARGET,MEK INHIBITION,GENE,MYCN,CANCER},
  language     = {eng},
  number       = {14},
  pages        = {3327--3339},
  title        = {Upregulation of MAPK negative feedback regulators and RET in mutant ALK neuroblastoma : implications for targeted treatment},
  url          = {http://dx.doi.org/10.1158/1078-0432.CCR-14-2024},
  volume       = {21},
  year         = {2015},
}

Chicago
Lambertz, Irina, Candy Kumps, Shana Claeys, Sven Lindner, Anneleen Beckers, Els Janssens, Daniel R Carter, et al. 2015. “Upregulation of MAPK Negative Feedback Regulators and RET in Mutant ALK Neuroblastoma : Implications for Targeted Treatment.” Clinical Cancer Research 21 (14): 3327–3339.
APA
Lambertz, I., Kumps, C., Claeys, S., Lindner, S., Beckers, A., Janssens, E., Carter, D. R., et al. (2015). Upregulation of MAPK negative feedback regulators and RET in mutant ALK neuroblastoma : implications for targeted treatment. CLINICAL CANCER RESEARCH, 21(14), 3327–3339.
Vancouver
1.
Lambertz I, Kumps C, Claeys S, Lindner S, Beckers A, Janssens E, et al. Upregulation of MAPK negative feedback regulators and RET in mutant ALK neuroblastoma : implications for targeted treatment. CLINICAL CANCER RESEARCH. 2015;21(14):3327–39.
MLA
Lambertz, Irina, Candy Kumps, Shana Claeys, et al. “Upregulation of MAPK Negative Feedback Regulators and RET in Mutant ALK Neuroblastoma : Implications for Targeted Treatment.” CLINICAL CANCER RESEARCH 21.14 (2015): 3327–3339. Print.